JP2025501411A5 - - Google Patents
Info
- Publication number
- JP2025501411A5 JP2025501411A5 JP2024561731A JP2024561731A JP2025501411A5 JP 2025501411 A5 JP2025501411 A5 JP 2025501411A5 JP 2024561731 A JP2024561731 A JP 2024561731A JP 2024561731 A JP2024561731 A JP 2024561731A JP 2025501411 A5 JP2025501411 A5 JP 2025501411A5
- Authority
- JP
- Japan
- Prior art keywords
- disorder
- compound
- depression
- free form
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263296137P | 2022-01-03 | 2022-01-03 | |
| US63/296,137 | 2022-01-03 | ||
| US202263314466P | 2022-02-27 | 2022-02-27 | |
| US63/314,466 | 2022-02-27 | ||
| US202263345002P | 2022-05-23 | 2022-05-23 | |
| US63/345,002 | 2022-05-23 | ||
| US202263394565P | 2022-08-02 | 2022-08-02 | |
| US63/394,565 | 2022-08-02 | ||
| US202263384988P | 2022-11-25 | 2022-11-25 | |
| US63/384,988 | 2022-11-25 | ||
| PCT/US2023/010055 WO2023130119A1 (en) | 2022-01-03 | 2023-01-03 | Deuterated organic compounds and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025501411A JP2025501411A (ja) | 2025-01-17 |
| JP2025501411A5 true JP2025501411A5 (https=) | 2026-01-15 |
Family
ID=87000385
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024561731A Pending JP2025501411A (ja) | 2022-01-03 | 2023-01-03 | 重水素化有機化合物およびその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US12606523B2 (https=) |
| EP (1) | EP4460292A4 (https=) |
| JP (1) | JP2025501411A (https=) |
| KR (1) | KR20240132477A (https=) |
| AU (1) | AU2023204433A1 (https=) |
| CA (1) | CA3242755A1 (https=) |
| IL (1) | IL313999A (https=) |
| MX (1) | MX2024008371A (https=) |
| TW (1) | TW202333671A (https=) |
| WO (1) | WO2023130119A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202517609A (zh) | 2023-07-02 | 2025-05-01 | 美商英格瑞治療公司 | 氘化有機化合物及其用途(二) |
| WO2026011157A1 (en) | 2024-07-05 | 2026-01-08 | Engrail Therapeutics, Inc. | Crystalline forms |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4197243A (en) * | 1975-04-02 | 1980-04-08 | Yamanouchi Pharmaceutical Co., Ltd. | N-1-Benzyl-3-pyrrolidinyl-4-dimethylamino benzamide derivatives |
| US4210660A (en) | 1978-12-20 | 1980-07-01 | Yamanouchi Pharmaceutical Co., Ltd. | Benzamide derivatives |
| TW212139B (https=) | 1991-04-15 | 1993-09-01 | Yamanouchi Pharma Co Ltd | |
| SK281042B6 (sk) | 1992-09-18 | 2000-11-07 | Yamanouchi Pharmaceutical Co., Ltd | Prípravok hydrogélového typu s ustáleným uvoľňovaním |
| EP0667867A1 (en) | 1992-11-05 | 1995-08-23 | Smithkline Beecham Plc | Piperidine derivatives as 5-ht4 receptor antagonists |
| US6872405B2 (en) | 2001-05-10 | 2005-03-29 | Yamanouchi Pharmaceutical Co., Ltd. | Quick-disintegrating tablet in buccal cavity and manufacturing method thereof |
| KR102373288B1 (ko) | 2013-12-03 | 2022-03-10 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 신규한 방법 |
| CN104744333A (zh) | 2013-12-26 | 2015-07-01 | 张云 | 一种奈莫必利的生产方法 |
| US20190343827A1 (en) | 2018-05-08 | 2019-11-14 | Izumi Technology, Llc | Deuterated analogs of tariquidar |
| MX2021010198A (es) | 2019-02-27 | 2021-09-21 | Univ California | Indoles n-sustituidos y otros heterociclos para el tratamiento de trastornos cerebrales. |
| US20210017160A1 (en) | 2019-07-16 | 2021-01-21 | Cyclerion Therapeutics, Inc. | DEUTERATED sGC STIMULATORS |
| TW202340145A (zh) | 2022-01-03 | 2023-10-16 | 美商恩格瑞爾療法公司 | 氘化有機化合物及其用途 |
| TW202517609A (zh) | 2023-07-02 | 2025-05-01 | 美商英格瑞治療公司 | 氘化有機化合物及其用途(二) |
-
2023
- 2023-01-03 TW TW112100105A patent/TW202333671A/zh unknown
- 2023-01-03 KR KR1020247025930A patent/KR20240132477A/ko active Pending
- 2023-01-03 JP JP2024561731A patent/JP2025501411A/ja active Pending
- 2023-01-03 WO PCT/US2023/010055 patent/WO2023130119A1/en not_active Ceased
- 2023-01-03 AU AU2023204433A patent/AU2023204433A1/en active Pending
- 2023-01-03 EP EP23735189.5A patent/EP4460292A4/en active Pending
- 2023-01-03 CA CA3242755A patent/CA3242755A1/en active Pending
- 2023-01-03 IL IL313999A patent/IL313999A/en unknown
-
2024
- 2024-07-02 MX MX2024008371A patent/MX2024008371A/es unknown
- 2024-07-03 US US18/763,819 patent/US12606523B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025501411A5 (https=) | ||
| JP7278359B2 (ja) | Ｓｈｐ２の活性を阻害するための化合物および組成物 | |
| JP2025501410A5 (https=) | ||
| JP2009538853A5 (https=) | ||
| JP2023527575A5 (https=) | ||
| JP2020023528A5 (https=) | ||
| RU2015143466A (ru) | Нейроактивные стероиды и способы их применения | |
| CN118576586A (zh) | 治疗神经和精神疾病的方法 | |
| JP2018070614A5 (https=) | ||
| RU2009103307A (ru) | ПРОИЗВОДНЫЕ ИМИДАЗО[1, 2-a]ПИРИДИН-2-КАРБОКСАМИДОВ, ИХ ПОЛУЧЕНИЕ И ПРИМЕНЕНИЕ В ТЕРАПИИ | |
| JP2008531714A (ja) | 不安障害の治療用及び／又は予防用の医薬組成物 | |
| RU2009136330A (ru) | Тетрагидроизохинолиновые соединения в качестве модуляторов гистаминового н3 рецептора | |
| JP2022549335A5 (https=) | ||
| JP2020517607A5 (https=) | ||
| JP2022515766A5 (https=) | ||
| AU2016228207A1 (en) | Sigma ligands for the prevention or treatment of pain induced by chemotherapy | |
| RU2015112914A (ru) | Бензимидазолы в качестве активных агентов для центральной нервной системы | |
| JP2020511515A5 (https=) | ||
| JP2019534327A5 (https=) | ||
| JP2017526659A5 (https=) | ||
| KR20180080305A (ko) | 인돌린-2-온 유도체 | |
| RU2006124863A (ru) | Трициклические производные индолгидроксиэтиламина и их применение при лечении болезни альцгеймера | |
| JP2022513933A5 (https=) | ||
| JP2017523201A5 (https=) | ||
| US20180244623A1 (en) | N-methyl-D-aspartate Receptor (NMDAR) Potentiators, Pharmaceutical Compositions, And Uses Related Thereto |